Content about Carpuject

November 12, 2013

Hospira had sales of $1 billion in third quarter 2013, the generic drug maker said.

LAKE FOREST, Ill. — Hospira had sales of $1 billion in third quarter 2013, the generic drug maker said.

Hospira, which specializes in making generic injectable drugs, as well as biosimilars for the European market, said the sales figures for the quarter were a 1.4% increase over the $994 million in sales reported in third quarter 2012. Profits for the quarter were $84.5 billion, compared with $78.4 billion during the same period last year.

August 30, 2012

Generic drug maker Hospira has acquired a manufacturing and research and development center from an Indian drug maker for $200 million, Hospira said Wednesday.

LAKE FOREST, Ill. — Generic drug maker Hospira has acquired a manufacturing and research and development center from an Indian drug maker for $200 million, Hospira said Wednesday.

Hospira said it bought the Food and Drug Administration-approved active pharmaceutical ingredient factory and R&D facility in Aurangabad, India, from Orchid Chemicals and Pharmaceuticals, saying it would reduce Hospira's costs, support its supplying of antibiotics and pave the way for future API development.

November 22, 2010

A drug maker has named a former executive at Tengion to the newly created post of SVP quality ...

LAKE FOREST, Ill. A drug maker has named a former executive at Tengion to the newly created post of SVP quality.

Hospira said Francois Dubois would be responsible for the global specialty pharmaceutical and medication delivery company's global quality systems, and will serve as a member of Hospira's senior leadership team. Dubois will report directly to Christopher Begley, Hospira's chairman and CEO.

June 2, 2010

Generic injectable drug maker Hospira said Thursday that it had extended its $145 million offer...